Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Depreciation & Amortization (CF) (2016 - 2024)

Historic Depreciation & Amortization (CF) for Bio Green Med Solution (BGMS) over the last 15 years, with Q4 2024 value amounting to $1000.0.

  • Bio Green Med Solution's Depreciation & Amortization (CF) fell 8750.0% to $1000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year decrease of 9230.77%. This contributed to the annual value of $6000.0 for FY2024, which is 8064.52% down from last year.
  • As of Q4 2024, Bio Green Med Solution's Depreciation & Amortization (CF) stood at $1000.0, which was down 8750.0% from $1000.0 recorded in Q3 2024.
  • In the past 5 years, Bio Green Med Solution's Depreciation & Amortization (CF) registered a high of $17000.0 during Q2 2021, and its lowest value of $1000.0 during Q3 2024.
  • Over the past 5 years, Bio Green Med Solution's median Depreciation & Amortization (CF) value was $7000.0 (recorded in 2021), while the average stood at $6600.0.
  • Per our database at Business Quant, Bio Green Med Solution's Depreciation & Amortization (CF) soared by 24000.0% in 2021 and then crashed by 8750.0% in 2024.
  • Over the past 5 years, Bio Green Med Solution's Depreciation & Amortization (CF) (Quarter) stood at $4000.0 in 2020, then soared by 75.0% to $7000.0 in 2021, then grew by 14.29% to $8000.0 in 2022, then changed by 0.0% to $8000.0 in 2023, then tumbled by 87.5% to $1000.0 in 2024.
  • Its Depreciation & Amortization (CF) was $1000.0 in Q4 2024, compared to $1000.0 in Q3 2024 and $2000.0 in Q2 2024.